Literature DB >> 12499219

gyrA mutations in ciprofloxacin-resistant Bartonella bacilliformis strains obtained in vitro.

Michael F Minnick1, Zachary R Wilson, Laura S Smitherman, D Scott Samuels.   

Abstract

We isolated and characterized mutants of Bartonella bacilliformis that are resistant to the fluoroquinolone antibiotic ciprofloxacin, which targets the A subunit of DNA gyrase. Mutants had single point mutations in the gyrA gene that changed either Asp-90 to Gly or Asp-95 to Asn and had 3- or 16-fold higher resistance, respectively, to ciprofloxacin than did wild-type B. bacilliformis. Asp-95 is homologous to Asp-87 of Escherichia coli GyrA and is a common residue mutated in fluoroquinolone-resistant strains of other bacteria. This is the first report of a mutation at an Asp-90 homologue, which corresponds to Asp-82 in E. coli GyrA.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12499219      PMCID: PMC148966          DOI: 10.1128/AAC.47.1.383-386.2003

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  23 in total

1.  Impact of gyrA and parC mutations on quinolone resistance, doubling time, and supercoiling degree of Escherichia coli.

Authors:  S Bagel; V Hüllen; B Wiedemann; P Heisig
Journal:  Antimicrob Agents Chemother       Date:  1999-04       Impact factor: 5.191

Review 2.  The clinical spectrum of bacillary angiomatosis.

Authors:  G F Webster; C J Cockerell; A E Friedman-Kien
Journal:  Br J Dermatol       Date:  1992-06       Impact factor: 9.302

Review 3.  DNA gyrase, topoisomerase IV, and the 4-quinolones.

Authors:  K Drlica; X Zhao
Journal:  Microbiol Mol Biol Rev       Date:  1997-09       Impact factor: 11.056

4.  Mutations in topoisomerase IV and DNA gyrase of Staphylococcus aureus: novel pleiotropic effects on quinolone and coumarin activity.

Authors:  B Fournier; D C Hooper
Journal:  Antimicrob Agents Chemother       Date:  1998-01       Impact factor: 5.191

5.  Requirement of topoisomerase IV parC and parE genes for cell cycle progression and developmental regulation in Caulobacter crescentus.

Authors:  D Ward; A Newton
Journal:  Mol Microbiol       Date:  1997-12       Impact factor: 3.501

6.  DNA gyrase and topoisomerase IV are dual targets of clinafloxacin action in Streptococcus pneumoniae.

Authors:  X S Pan; L M Fisher
Journal:  Antimicrob Agents Chemother       Date:  1998-11       Impact factor: 5.191

7.  Cloning and primary structure of Staphylococcus aureus DNA topoisomerase IV: a primary target of fluoroquinolones.

Authors:  L Ferrero; B Cameron; B Manse; D Lagneaux; J Crouzet; A Famechon; F Blanche
Journal:  Mol Microbiol       Date:  1994-08       Impact factor: 3.501

Review 8.  DNA gyrase: structure and function.

Authors:  R J Reece; A Maxwell
Journal:  Crit Rev Biochem Mol Biol       Date:  1991       Impact factor: 8.250

9.  The mechanism of inhibition of topoisomerase IV by quinolone antibacterials.

Authors:  A B Khodursky; N R Cozzarelli
Journal:  J Biol Chem       Date:  1998-10-16       Impact factor: 5.157

10.  Mutations in Bartonella bacilliformis gyrB confer resistance to coumermycin A1.

Authors:  J M Battisti; L S Smitherman; D S Samuels; M F Minnick
Journal:  Antimicrob Agents Chemother       Date:  1998-11       Impact factor: 5.191

View more
  10 in total

Review 1.  Carrion's Disease: the Sound of Silence.

Authors:  Cláudia Gomes; Joaquim Ruiz
Journal:  Clin Microbiol Rev       Date:  2017-11-29       Impact factor: 26.132

2.  Studies on the antimicrobial properties of N-acylated ciprofloxacins.

Authors:  Ryan Cormier; Whittney N Burda; Lacey Harrington; Jordan Edlinger; Karthik M Kodigepalli; John Thomas; Rebecca Kapolka; Glen Roma; Burt E Anderson; Edward Turos; Lindsey N Shaw
Journal:  Bioorg Med Chem Lett       Date:  2012-07-01       Impact factor: 2.823

Review 3.  Bartonella bacilliformis: a systematic review of the literature to guide the research agenda for elimination.

Authors:  Nuria Sanchez Clemente; Cesar A Ugarte-Gil; Nelson Solórzano; Ciro Maguiña; Paul Pachas; David Blazes; Robin Bailey; David Mabey; David Moore
Journal:  PLoS Negl Trop Dis       Date:  2012-10-25

4.  Shared and Unique Evolutionary Trajectories to Ciprofloxacin Resistance in Gram-Negative Bacterial Pathogens.

Authors:  Jaime E Zlamal; Semen A Leyn; Mallika Iyer; Marinela L Elane; Nicholas A Wong; James W Wamsley; Maarten Vercruysse; Fernando Garcia-Alcalde; Andrei L Osterman
Journal:  mBio       Date:  2021-06-22       Impact factor: 7.867

5.  Whole Genome Sequencing and Comparative Analysis of Bartonella bacilliformis Strain INS, the Causative Agent of Carrion's Disease.

Authors:  D Tarazona; C Padilla; O Cáceres; J D Montenegro; H Bailón; G Ventura; G Mendoza; E Anaya; H Guio
Journal:  Genome Announc       Date:  2013-02-14

Review 6.  Oroya fever and verruga peruana: bartonelloses unique to South America.

Authors:  Michael F Minnick; Burt E Anderson; Amorce Lima; James M Battisti; Phillip G Lawyer; Richard J Birtles
Journal:  PLoS Negl Trop Dis       Date:  2014-07-17

7.  An Outbreak of Bartonella bacilliformis in an Endemic Andean Community.

Authors:  Nuria Sanchez Clemente; Cesar Ugarte-Gil; Nelson Solorzano; Ciro Maguiña; David Moore
Journal:  PLoS One       Date:  2016-03-18       Impact factor: 3.240

8.  Development and characterisation of highly antibiotic resistant Bartonella bacilliformis mutants.

Authors:  Cláudia Gomes; Sandra Martínez-Puchol; Lidia Ruiz-Roldán; Maria J Pons; Juana Del Valle Mendoza; Joaquim Ruiz
Journal:  Sci Rep       Date:  2016-09-26       Impact factor: 4.379

9.  A bacterial toxin-antitoxin module is the origin of inter-bacterial and inter-kingdom effectors of Bartonella.

Authors:  Alexander Harms; Marius Liesch; Jonas Körner; Maxime Québatte; Philipp Engel; Christoph Dehio
Journal:  PLoS Genet       Date:  2017-10-26       Impact factor: 5.917

Review 10.  A Review of Scrub Typhus (Orientia tsutsugamushi and Related Organisms): Then, Now, and Tomorrow.

Authors:  Alison Luce-Fedrow; Marcie L Lehman; Daryl J Kelly; Kristin Mullins; Alice N Maina; Richard L Stewart; Hong Ge; Heidi St John; Ju Jiang; Allen L Richards
Journal:  Trop Med Infect Dis       Date:  2018-01-17
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.